PREVIOUS QUESTION:

 

NEXT QUESTION:

 

What are side effects epi-on corneal cross-linking?

ANSWER

Epi-on corneal cross-linking usually doesn’t have any side effects.

From: What Is Corneal Cross-Linking? WebMD Medical Reference

SOURCES:

National Keratoconus Foundation: “About Keratoconus Eye Disease,” “How Keratoconus is Treated,” “Crosslinking Update: Understanding what FDA Approval Means.”

Mayo Clinic: “Keratoconus: Diagnosis and Treatment.”

University of Miami Health System: Bascom Palmer Eye Institute: “Corneal Cross-Linking.”

American Academy of Ophthalmology: “Corneal Collagen Cross-linking Approved to Treat Keratoconus in U.S.,” “Ectasia After Lasik,” “Keratoconus Treatment.”

American Optometric Association: “FDA approves first corneal cross-linking system for treatment.”

University of Michigan Kellogg Eye Center: “Corneal Cross-Linking (Collagen Cross-Linking).”

Middle East African Journal of Ophthalmology : “Corneal Collagen Cross-Linking.”

Johns Hopkins Medicine: “Corneal Collagen Cross-linking at the Johns Hopkins Wilmer Eye Institute.”

American Keratoconus Association: “Cornea Collagen Crosslinking with Riboflavin.”

MedStar Georgetown University Hospital: “Corneal Cross-linking.”

USC Roski Eye Institute: “Keratoconus and Corneal Cross-Linking (CXL) Treatment.”

Journal of Ophthalmology : “Complications of Corneal Collagen Cross-Linking.”

FDA: “Riboflavin Ophthalmic Solution/KXL System for the Treatment of Progressive Keratoconus or Corneal Ectasia Following Refractive Surgery.”

NIH National Eye Institute: “Facts About the Cornea and Corneal Disease.”

Medscape: “Corneal Crosslinking: Is Using an Epithelium-On Technique Effective?”

University of Chicago Department of Ophthalmology and Visual Science: “Corneal Cross-linking FAQs.”

Reviewed by Alan Kozarsky on July 10, 2019

SOURCES:

National Keratoconus Foundation: “About Keratoconus Eye Disease,” “How Keratoconus is Treated,” “Crosslinking Update: Understanding what FDA Approval Means.”

Mayo Clinic: “Keratoconus: Diagnosis and Treatment.”

University of Miami Health System: Bascom Palmer Eye Institute: “Corneal Cross-Linking.”

American Academy of Ophthalmology: “Corneal Collagen Cross-linking Approved to Treat Keratoconus in U.S.,” “Ectasia After Lasik,” “Keratoconus Treatment.”

American Optometric Association: “FDA approves first corneal cross-linking system for treatment.”

University of Michigan Kellogg Eye Center: “Corneal Cross-Linking (Collagen Cross-Linking).”

Middle East African Journal of Ophthalmology : “Corneal Collagen Cross-Linking.”

Johns Hopkins Medicine: “Corneal Collagen Cross-linking at the Johns Hopkins Wilmer Eye Institute.”

American Keratoconus Association: “Cornea Collagen Crosslinking with Riboflavin.”

MedStar Georgetown University Hospital: “Corneal Cross-linking.”

USC Roski Eye Institute: “Keratoconus and Corneal Cross-Linking (CXL) Treatment.”

Journal of Ophthalmology : “Complications of Corneal Collagen Cross-Linking.”

FDA: “Riboflavin Ophthalmic Solution/KXL System for the Treatment of Progressive Keratoconus or Corneal Ectasia Following Refractive Surgery.”

NIH National Eye Institute: “Facts About the Cornea and Corneal Disease.”

Medscape: “Corneal Crosslinking: Is Using an Epithelium-On Technique Effective?”

University of Chicago Department of Ophthalmology and Visual Science: “Corneal Cross-linking FAQs.”

Reviewed by Alan Kozarsky on July 10, 2019

NEXT QUESTION:

What is meibomian gland dysfunction (MGD)?

WAS THIS ANSWER HELPFUL

THIS TOOL DOES NOT PROVIDE MEDICAL ADVICE. It is intended for general informational purposes only and does not address individual circumstances. It is not a substitute for professional medical advice, diagnosis or treatment and should not be relied on to make decisions about your health. Never ignore professional medical advice in seeking treatment because of something you have read on the WebMD Site. If you think you may have a medical emergency, immediately call your doctor or dial 911.

    This tool does not provide medical advice. See additional information.

    Other Answers On: